Dianthus Therapeutics Inc.
DNTH | NASDAQ
$98.85
+$2.38 (+2.47%)
Sep 22, 2026, 1:18 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -233.08M | -173.66M | -162.34M | -126.35M | -114.75M | -100.73M | -84.97M | -67.09M | -56.68M | -50.21M | -43.56M | -43.11M | -36.13M | -42.26M | -58.12M | -67.3M | -76.94M | -76.6M | -71.14M | -70.01M | -70.26M | -72.41M |
Depreciation & Amortization | 341K | 371K | 428K | 409K | 426K | 438K | 412K | 437K | 340K | 313K | 287K | 233K | 1.43M | 2.54M | 3.67M | 4.15M | 3.47M | 2.76M | 2.02M | 1.98M | 1.94M | 1.96M |
Stock-Based Compensation | 44.87M | 28.08M | 22.79M | 20.73M | 18.78M | 16.17M | 12.89M | 9.7M | 7.04M | 4.4M | 2.9M | 2.69M | 1.51M | 1.05M | 513K | n/a | n/a | n/a | 2.19M | 4.52M | 6.89M | 9.39M |
Other Working Capital | -685K | 1.06M | 4.69M | -734K | -7.59M | -8.75M | -8.21M | -7.1M | 4.84M | 6.36M | 5.91M | 9.6M | -1.54M | -1.25M | -2.78M | -3.36M | -3.4M | -1.61M | -806K | -288K | 1.53M | -1.72M |
Other Non-Cash Items | -11.12M | -5.68M | -6.67M | -8.14M | -8.25M | -7.55M | -6.17M | -4.12M | 3.21M | 3.42M | 3.58M | 3.71M | 21.98M | 24.15M | 26.53M | 29.19M | 10.24M | 10.63M | 8.92M | 6.73M | 2.78M | 472K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 14.76M | 20.61M | 16.73M | 3.82M | 3.57M | 803K | -351K | -1.52M | 6.26M | 12.05M | 11.41M | 14.11M | 3.72M | -5.08M | -1.65M | -1.95M | -3.12M | 710K | -1.53M | -791K | 718K | -3.55M |
Operating Cash Flow | -184.23M | -130.29M | -129.06M | -109.52M | -100.23M | -90.87M | -78.18M | -62.59M | -39.83M | -30.03M | -25.37M | -22.37M | -7.49M | -19.61M | -29.07M | -35.91M | -66.35M | -62.5M | -59.53M | -57.57M | -57.94M | -64.14M |
Capital Expenditures | -344K | -199K | -213K | -106K | -126K | -97K | -105K | -84K | 86K | 82K | 100K | 81K | -18K | -126K | -139K | -125K | -1.3M | -1.28M | -1.26M | -1.46M | -351K | -276K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.38M | -5.38M | -5.38M | -5.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.38B | -606.28M | -435.01M | -488.36M | -486.86M | -460.56M | -413.71M | -331.86M | -74.94M | -68.13M | -51.51M | -39.92M | -25.42M | -25.42M | -61.68M | -92.35M | -85.43M | -85.43M | -45.31M | -90.76M | -90.76M | -90.76M |
Sales Maturities Of Investments | 467.33M | 334.88M | 312.39M | 305.32M | 245.75M | 194.14M | 127M | 60M | 50.79M | 64.67M | 71.67M | 55.67M | 45.89M | 24M | 2M | 35M | 52.5M | 82.5M | 90M | 75M | 77.5M | 62.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -910.54M | -271.6M | -122.83M | -183.15M | -241.23M | -266.51M | -286.81M | -271.94M | -29.46M | -8.76M | 14.88M | 10.45M | 20.45M | -1.54M | -59.82M | -57.48M | -34.23M | -4.21M | 43.43M | -17.22M | -13.61M | -28.54M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.64M | 15.64M | 15.64M | 15.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 317K | 317K | 317K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 964.79M | 280.13M | 280.13M | 476K | 476K | -217.1M | -229.25M | -234.59M | -168.15M | 49.42M | 61.57M | 66.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 1.77B | 1.02B | 280.13M | 314.92M | 40.7M | 37.94M | 255.62M | 211.08M | 364.86M | 367.06M | 149.21M | 154.08M | 96.63M | 96.68M | 96.68M | 96.8M | 376K | 89.18M | 89.6M | 90.66M | 90.29M | 67.03M |
Net Cash Flow | 673.83M | 617.49M | 28.23M | 22.25M | -300.93M | -319.61M | -109.53M | -123.61M | 251.54M | 284.23M | 94.67M | 98.11M | 7.66M | -26.41M | -94.14M | -98.51M | -100.2M | 22.48M | 73.5M | 15.86M | 18.75M | -25.64M |
Free Cash Flow | -184.58M | -130.49M | -129.27M | -109.63M | -100.36M | -90.97M | -78.29M | -62.67M | -39.74M | -29.95M | -25.27M | -22.29M | -7.51M | -19.74M | -29.21M | -36.03M | -67.65M | -63.78M | -60.8M | -59.04M | -58.29M | -64.42M |
Adj. Free Cash Flow | -229.45M | -158.57M | -152.07M | -130.36M | -119.14M | -107.14M | -91.18M | -72.38M | -46.78M | -34.35M | -28.17M | -24.98M | -9.02M | -20.79M | -29.72M | -36.03M | -67.65M | -63.78M | -62.99M | -63.56M | -65.18M | -73.81M |
Maintenance CapEx | -222K | -199K | -189K | -51K | -46K | n/a | n/a | -10K | 135K | 135K | 135K | 145K | 92K | -37K | -64K | -79K | -1.3M | -1.28M | -1.26M | -1.46M | -351K | -276K |
Growth CapEx | -122K | n/a | -24K | -55K | -80K | -97K | -105K | -74K | -49K | -53K | -35K | -64K | -110K | -89K | -75K | -46K | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -184.45M | -130.49M | -129.25M | -109.57M | -100.28M | -90.87M | -78.18M | -62.6M | -39.69M | -29.89M | -25.24M | -22.22M | -7.4M | -19.65M | -29.13M | -35.99M | -67.65M | -63.78M | -60.8M | -59.04M | -58.29M | -64.42M |
Add to Watchlist
Select watchlists to add or remove DNTH